Pilocarpine Hydrochloride Ophthalmic Solution shortage
To Be Discontinued 5 presentations · 1 manufacturers · first FDA posting 2026-03-24 · last update 2026-03-24
Manufacturers: AbbVie Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 03/24/2026 Updated 03/24/2026 Discontinued 03/24/2026 |
| Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 03/24/2026 Updated 03/24/2026 Discontinued 03/24/2026 |
| Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 03/24/2026 Updated 03/24/2026 Discontinued 03/24/2026 |
| Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 03/24/2026 Updated 03/24/2026 Discontinued 03/24/2026 |
| Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 03/24/2026 Updated 03/24/2026 Discontinued 03/24/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)